XO Life receives two million euros

Berlin-based medtech startup XO Life has raised an impressive two million euros in its latest financing round to further advance the development of its innovative patient insights platform. This platform enables patients to record and share their experiences with drugs and therapies, including side effects, in a standardized and privacy-compliant manner. Investors include the international healthcare VC SeedLink, the corporate VC MediVentures as well as the direct investment platform Aescuvest and other specialists from the healthcare technology sector.

XO Life aims to become the largest real-world evidence platform for patient insights. The start-up is working closely with the PROMIS Institute Germany, Charité and various pharmaceutical manufacturers. Around 25,000 people are already using the platform to contribute their experiences in healthcare.